These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 334065

  • 21. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
    Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31988099
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A, Pekmezović M, Barać A, Crnčević Radović L, Arsić Arsenijević V.
    J Mycol Med; 2012 Sep 24; 22(3):243-8. PubMed ID: 23518082
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ, DeLallo VC, Lewis RE, Ernst EJ, Klepser ME.
    Diagn Microbiol Infect Dis; 2001 Nov 24; 41(3):121-6. PubMed ID: 11750164
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Synergism of polyene antibiotics with 5-fluorocytosine.
    Polak A.
    Chemotherapy; 1978 Nov 24; 24(1):2-16. PubMed ID: 338264
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Further experimental data on clotrimazole: effectiveness against Cryptococcus neoformans, Sporothrix schenkii and Blastomyces dermatitidis Gilchrist].
    Barfuss T, Seeliger HP, Plempel M.
    Mykosen; 1975 May 24; 18(5):221-32. PubMed ID: 1099444
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
    Bava AJ, Negroni R.
    Eur J Epidemiol; 1992 May 24; 8(3):422-6. PubMed ID: 1327864
    [Abstract] [Full Text] [Related]

  • 35. Flucytosine and cryptococcosis: which in vitro test is the best predictor of outcome?
    Viviani MA, Esposto MC, Cogliati M, Tortorano AM.
    J Chemother; 2003 Apr 24; 15(2):124-8. PubMed ID: 12797387
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.
    Barchiesi F, Gallo D, Caselli F, Di Francesco LF, Arzeni D, Giacometti A, Scalise G.
    J Antimicrob Chemother; 1999 Jul 24; 44(1):65-70. PubMed ID: 10459811
    [Abstract] [Full Text] [Related]

  • 39. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC.
    Antimicrob Agents Chemother; 1982 Nov 24; 22(5):763-70. PubMed ID: 6295266
    [Abstract] [Full Text] [Related]

  • 40. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
    Larsen RA, Bauer M, Thomas AM, Graybill JR.
    Antimicrob Agents Chemother; 2004 Mar 24; 48(3):985-91. PubMed ID: 14982793
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.